Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Fred Kolhouse
J. Fred Kolhouse
University of Colorado Denver
Immunology
Multiple myeloma
Medicine
Melphalan
Bortezomib
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Unremitting Presence of Marrow Immunoglobulin Heavy Chain Gene Rearrangement (IGH-GR) 3 Months Following Autotransplant Is Associated with Poor Outcome in Disease Control in Patients with Multiple Myeloma (MM).
2009
Blood
Choon Kee Lee
Qi Wei
Mark A. Lovell
Karen Swisshelm
John Ryder
Han Myint
J. Fred Kolhouse
William A. Robinson
Show All
Source
Cite
Save
Citations (0)
An Outcome Study On Survival and Disease Control in Patients with High-Risk Multiple Myeloma (MM) for Relapse, Treated with High-Dose Melphalan Combined with Bortezomib for Autotransplant Followed by Post-Transplant Maintenance with Bortezomib and Lenalidomide.
2009
Blood
Choon Kee Lee
Jeff Kaiser
Han Myint
Mary Berg
J. Fred Kolhouse
William A. Robinson
Show All
Source
Cite
Save
Citations (1)
Presence of Dysregulated Immune Recovery (IMD) Following Autotransplant May Change the Type of Predominant Serum Light Chain and Elevate the Level in Patients with Multiple Myeloma (MM).
2009
Blood
Choon Kee Lee
Mary Berg
John Ryder
Han Myint
J. Fred Kolhouse
William A. Robinson
Show All
Source
Cite
Save
Citations (0)
1